- Published at
- by zacks.com
neutral
neutral
Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know
Sensus Healthcare, Inc. (SRTS) closed at $4.16 in the latest trading session, marking a -9.17% move from the prior day.
News for Sensus Healthcare, Inc. (SRTS)
- Published at
- by zacks.com
neutralneutralSensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors
Sensus Healthcare, Inc. (SRTS) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day.- Published at
- by gurufocus.com
positivepositiveSensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists
Sensus Healthcare, Inc. (Nasdaq: SRTS) (Sensus or the Company),a medical device company specializing in highly effective, non-invasive, minimally-invasive and- Published at
- by zacks.com
neutralneutralSensus Healthcare, Inc. (SRTS) Stock Moves 1.91%: What You Should Know
In the closing of the recent trading day, Sensus Healthcare, Inc. (SRTS) stood at $4.80, denoting a +1.91% move from the preceding trading day.- Published at
- by zacks.com
positivepositiveIs It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), Sensus Healthcare (SRTS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?- Published at
- by gurufocus.com
neutralneutralSensus Healthcare (SRTS) Price Target Lowered by Maxim Group | SRTS Stock News
On May 19, 2025, Maxim Group maintained their Buy rating for Sensus Healthcare (SRTS), while adjusting their price target for the company. Analyst Anthony Vende- Published at
- by gurufocus.com
positivepositiveSensus Healthcare (SRTS) Price Target Reduced by Maxim to $10 | SRTS Stock News
Maxim has revised its price target for Sensus Healthcare (SRTS), bringing it down from $14 to $10 while maintaining a Buy rating on the stock. This adjustment c- Published at
- by gurufocus.com
positivepositiveSensus Healthcare Inc (SRTS) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth and Innovation
Release Date: May 15, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Sensus Healthcare- Published at
- by gurufocus.com
neutralneutralQ1 2025 Sensus Healthcare Inc Earnings Call Transcript
Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NSRTS.OQ - Sensus Healthcare IncQ1 2025 Sensus Healthcare Inc Earnings CallMay 15, 2025 / 08:30- Published at
- by seekingalpha.com
neutralneutralSensus Healthcare, Inc. (SRTS) Q1 2025 Earnings Call Transcript
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ETCompany ParticipantsTirth Patel - Alliance Advisors, IRJoe...- Published at
- by gurufocus.com
positivepositiveSensus Healthcare Reports First Quarter 2025 Financial Results
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatmen- Published at
- by gurufocus.com
positivepositiveSRTS Surpasses Revenue Expectations with Strategic Initiatives and Future Growth | SRTS Stock News
Sensus Healthcare (SRTS) reported first-quarter revenue of $8.3 million, exceeding the market consensus of $7.2 million. The company has made significant invest- Published at
- by gurufocus.com
positivepositiveSensus Healthcare Q1 2025 Earnings: Revenue Surpasses Estimates at $8.3M, EPS Misses at $(0.16)
Revenue: $8.3 million, surpassing the estimated $7.23 million.Net Loss: $2.6 million, or $(0.16) per share, compared to net income of $2.3 million, or $0.14 pe- Published at
- by zacks.com
positivepositiveSensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates
Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -500% and 14.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by gurufocus.com
positivepositiveEarnings To Watch: Sensus Healthcare Inc (SRTS) Reports Q1 2025 Result
Sensus Healthcare Inc (SRTS) is set to release its Q1 2025 earnings on May 15, 2025. The consensus estimate for Q1 2025 revenue is $7.23 million, and the earnin- Published at
- by zacks.com
positivepositiveSensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know
Sensus Healthcare, Inc. (SRTS) closed at $4.33 in the latest trading session, marking a +0.7% move from the prior day.- Published at
- by gurufocus.com
neutralneutralSensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments
May is Skin Cancer Awareness Month and Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimal- Published at
- by zacks.com
neutralneutralEarnings Preview: Sensus Healthcare, Inc. (SRTS) Q1 Earnings Expected to Decline
Sensus Healthcare (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.- Published at
- by gurufocus.com
positivepositiveSensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatmen- Published at
- by zacks.com
positivepositiveIs Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in Sensus Healthcare (SRTS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?